Zymeworks, Inc. (ZYME)
31.05
+1.38
(+4.65%)
USD |
NASDAQ |
Sep 02, 16:00
31.00
-0.05
(-0.16%)
After-Hours: 05:36
Zymeworks Cash from Operations (Annual) : -33.00M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -33.00M |
| December 31, 2024 | -110.06M |
| December 31, 2023 | -118.30M |
| December 31, 2022 | 144.11M |
| December 31, 2021 | -192.45M |
| December 31, 2020 | -151.40M |
| Date | Value |
|---|---|
| December 31, 2019 | -81.85M |
| December 31, 2018 | 24.18M |
| December 31, 2017 | 0.219M |
| December 31, 2016 | -35.25M |
| December 31, 2015 | -22.17M |
| December 31, 2014 | -7.016M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Theravance Biopharma, Inc. | 238.54M |
| BridgeBio Pharma, Inc. | -445.91M |
| Aprea Therapeutics, Inc. | -12.89M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |